Polaris Venture Management Co. V as of Sept. 30, 2019
Portfolio Holdings for Polaris Venture Management Co. V
Polaris Venture Management Co. V holds 11 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Phreesia | 49.2 | $87M | 3.6M | 24.24 | |
| Cardlytics (CDLX) | 28.7 | $51M | 1.5M | 33.52 | |
| Fate Therapeutics (FATE) | 10.1 | $18M | 1.1M | 15.53 | |
| Neuronetics (STIM) | 3.5 | $6.1M | 733k | 8.31 | |
| Selecta Biosciences (RNAC) | 2.8 | $4.9M | 2.8M | 1.75 | |
| Kala Pharmaceuticals | 2.6 | $4.6M | 1.2M | 3.81 | |
| X4 Pharmaceuticals (XFOR) | 2.2 | $4.0M | 312k | 12.71 | |
| Genocea Biosciences (GNCAQ) | 0.4 | $714k | 246k | 2.90 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 0.3 | $457k | 131k | 3.50 | |
| Pulmatrix | 0.2 | $295k | 359k | 0.82 | |
| Dare Bioscience (DARE) | 0.1 | $255k | 326k | 0.78 |
